Multi-billion-dollar company LifePlus Inc announced, at the Medical Wearables Conference in Santa Clara, Calif. Lifeleaf, a smart medical wearable device. Rocking in three sectors; Artificial Intelligence (AI), wearables, and diabetes monitoring, Lifeleaf is a non-invasive continuous blood glucose monitoring multi-sensor wearable device. In addition to blood glucose monitoring, the patent-pending multi-sensor device non-invasively monitors heart rate, blood pressure, respiration rate and oxygen saturation.

As part of LifePlus Inc’s burgeoning medical wearables category, LifeLeaf is the first of its kind to monitor the top five physiological health indicators non-invasively. “We have been in stealth mode, and today we are thrilled to announce the introduction of LifeLeaf as part of the burgeoning medical wearables category,” said serial tech-entrepreneur and White House Innovation Fellow John Trobough.

“Managing diabetes and other Chronic Diseases Require early and timely detection, rapid intervention and high compliance.”

He continues, “Managing diabetes and other chronic diseases require early and timely detection, rapid intervention and high compliance. LifeLeaf exceeds those requirements with its patent-pending open standards-based software stack and cloud-based analytics. LifeLeaf is different from any other product and software technology available – it is truly unique, and we are excited to make this multi-sensor capability available to companies and developers globally.”

ALSO READ: Level Smart Glasses: “A Medical Device, A Fashion Accessory and The World’s Oldest Form of Wearable Tech”

The multi-sensor wearable smartwatch continuously and non-invasively monitors and tracks significant chronic health risks such as diabetes, cardiac arrhythmia, congestive heart failure, COPD, sleep apnea and hypertension. It is a cloud-based AI solution with a user-interface that is simple and easy to use, as well as a connected mobile app that provides cloud-based analytics with real-time notifications. The tech product is targeted at the multi-billion-dollar medical wearables market, with an emphasis on the self-monitoring blood glucose market. The LifeLeaf wearable will be available later this year.

Share Your Tips & Correction